On April 25th, a Fed. Cir. panel of Judges Taranto, Clevenger and Chen affirmed the unenforceability of two Merck patents covering a drug presently marketed as Sovaldi(r) to treat hepatitis C, sofosbuvir. Gilead Sciences, Inc. v. Merck & Co., Appeal … Continue reading
The post Fed. Cir. Affirms Unclean Hands Defense in Gilead v. Merck appeared first on Patents4Life | Warren Woessner.